LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

ChargePoint Holdings price target cut in half at Needham as stock drops after warning

Clyde Edgerton by Clyde Edgerton
November 17, 2023
in Markets
ChargePoint Holdings price target cut in half at Needham as stock drops after warning
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


You might also like

Trump's approval holds steady despite unpopular policies, per new NYT poll

Trump is selling a strong economy. Voters aren’t buying it.

Former Trump statistics chief slams Friday firing of Erika McEntarfer

Needham analyst Chris Pierce on Friday cut his price target on ChargePoint Holdings Inc.’s stock
CHPT,
-36.10%
to $4 from $8 after the electric-vehicle charging specialist lost its top executive and forecast third-quarter sales below the consensus view. ChargePoint’s stock was down 29% in premarket trading Friday on heavy volume of 1.5 million shares. Pierce said ChargePoint continues to see order delays due to economic uncertainty. “We are still believers in EV adoption at the consumer and fleet levels given government incentives and the lower total cost of ownership…with near term weakness pushing out growth in our model,” Pierce said, while keeping a buy rating on the stock. Meanwhile, Oppenheimer cut its rating on ChargePoint to perform from outperform and removed its $13 price target for the stock. “We are stepping to the sidelines…given the management transition, choppy demand, and potential for further organizational changes,” said Oppenheimer analyst Colin Rusch.



Source link

Share30Tweet19
Previous Post

Retailers face exodus of marketing professionals as economic pressure continues

Next Post

Eli Lilly to build $2.5 billion plant in Germany to support rising demand for obesity, diabetes drugs

Clyde Edgerton

Clyde Edgerton

Recommended For You

Trump's approval holds steady despite unpopular policies, per new NYT poll
Markets

Trump's approval holds steady despite unpopular policies, per new NYT poll

September 30, 2025
Trump is selling a strong economy. Voters aren’t buying it.
Markets

Trump is selling a strong economy. Voters aren’t buying it.

September 13, 2025
Former Trump statistics chief slams Friday firing of Erika McEntarfer
Markets

Former Trump statistics chief slams Friday firing of Erika McEntarfer

August 3, 2025
Inside Trump’s chainsaw-wielding approach to one corner of government contracting
Markets

Inside Trump’s chainsaw-wielding approach to one corner of government contracting

May 25, 2025
Next Post
Eli Lilly to build .5 billion plant in Germany to support rising demand for obesity, diabetes drugs

Eli Lilly to build $2.5 billion plant in Germany to support rising demand for obesity, diabetes drugs

Related News

Strongest US dollar since 2022 bear market: 5 Things to know in Bitcoin this week

Strongest US dollar since 2022 bear market: 5 Things to know in Bitcoin this week

January 13, 2025
Boom in RWA tokenization expected after passing of GENIUS Act — Aptos exec

Boom in RWA tokenization expected after passing of GENIUS Act — Aptos exec

July 22, 2025
Chelsea XI vs Leicester: Starting lineup and confirmed team news

Chelsea XI vs Leicester: Starting lineup and confirmed team news

November 23, 2024

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?